CY2024 Q3
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| THE NEW YORK TIMES COMPANY | $324,329,000.00 | 2024-09-30 | View |
| BioLife Solutions, Inc. | $4,854,000.00 | 2024-09-30 | View |
| COGNEX CORP | $318,268,000.00 | 2024-09-29 | View |
| IONIS PHARMACEUTICALS, INC. | $687,173,000.00 | 2024-09-30 | View |
| NEUROCRINE BIOSCIENCES, INC. | $637,100,000.00 | 2024-09-30 | View |
| ELEVANCE HEALTH, INC. | $883,000,000.00 | 2024-09-30 | View |
| CARDIFF ONCOLOGY, INC. | $8,796,000.00 | 2024-09-30 | View |
| GLOBUS MEDICAL, INC. | $12,374,000.00 | 2024-09-30 | View |
| ARBUTUS BIOPHARMA CORP | $2,932,000.00 | 2024-09-30 | View |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | $23,857,000.00 | 2024-09-30 | View |
| Alkermes plc. | $18,800,000.00 | 2024-09-30 | View |
| Acumen Pharmaceuticals, Inc. | $58,374,000.00 | 2024-09-30 | View |
| MARCUS & MILLICHAP, INC. | $50,725,000.00 | 2024-09-30 | View |
| SENTINELONE, INC | $438,971,000.00 | 2024-10-31 | View |
| Inspire Medical Systems, Inc. | $112,875,000.00 | 2024-09-30 | View |
| Procore Technologies, Inc. | $52,283,000.00 | 2024-09-30 | View |
| ROOT, INC. | $264,100,000.00 | 2024-09-30 | View |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | $182,840,000.00 | 2024-09-30 | View |
| iTeos Therapeutics, Inc. | $159,150,000.00 | 2024-09-30 | View |
| NET Power Inc. | $18,215,000.00 | 2024-09-30 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations